Increased Trend of Breast Cancer Mortality in Iran

Abstract

Background: Breast cancer is the most commonly diagnosed cancer in women worldwide In Iran, it ranks first among cancers diagnosed in women and is the fifth most common cause of death. The aim of this study was to present the mortality trends from breast cancer for Iranian women during a period of almost a decade, in order to provide update information regarding the likely future. Methods: We analyzed National death Statistic reported by the Iranian Ministry of Health and Medical Education from 1995 to 2004 to generate annual mortality rates/100,000, overall, by age group (<15, 15-49 and ≥50 years of age) and age standardized rate (ASR). Results: The age standardized mortality rate of breast cancer increased dramatically during these years from 1.40 to 3.52 per 100,000 and its mortality was increasing 151.4% for Iranian women, although it seemed that the rate leveled off from 2002 to 2004. Moreover the increasing rate was higher for those aged between 15-49 compared to age >50 years old. Conclusion: There is an increasing trend for breast cancer mortality in Iran. Thus, health education programs to rectify the lack of women awareness about breast cancer signs and effective screening are urgently needed.

Health Beliefs and Breast Cancer Screening Behaviors among Iranian Female Health Workers

“…Epidemiological studies based on age-specific incidence in Iran showed that the cancer has the highest prevalence among 45-55 years old women (Taghavi et al, 2012). As other developing countries, these studies show that breast cancer tends to accumulate among younger women in our community.…”

Exploring Factors Related to Metastasis Free Survival in Breast Cancer Patients Using Bayesian Cure Models

“…Tohid Jafari-Koshki 1,2 , Marjan Mansourian 2,3 , Fariborz Mokarian 4 rank of incidence from the second to the first diagnosed cancer during these years, and it is currently the fifth most common cause of cancer death in women (Lamyian et al, 2007;Mousavi et al, 2007;Babu et al, 2011;Noroozi et al, 2011;Taghavi et al, 2012).…”

BRCA1 and BRCA2 Common Mutations in Iranian Breast Cancer Patients: a Meta Analysis

“…In Iran, even though the prevalence of breast cancer is lower compared to western countries, it is the most common malignancy among women (Rezaianzadeh et al, 2011). There is an increasing trend for breast cancer mortality in Iran during 1995 to 2004 from 1.40 to 3.52 per 100,000 (Taghavi et al, 2012). In the next decades, Iran will face an upsurge in the incidence of the disease (Dey and Soliman, 2010).…”